Role of TGFbeta signaling in skin carcinogenesis

X J Wang1

  • 1Departments of Dermatology, Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA. xwang@bcm.tmc.edu

Insights

Transforming growth factor beta (TGFbeta) signaling is crucial for epithelial homeostasis but paradoxically promotes skin cancer progression. Understanding its dual role in early versus late carcinogenesis is key to developing targeted therapies.

Area of Science:

  • Oncology
  • Cell Biology
  • Dermatology

Background:

  • The Transforming Growth Factor beta (TGFbeta) signaling pathway is vital for maintaining epithelial homeostasis.
  • Dysregulation of TGFbeta signaling is implicated in various cancers, including epithelial cancers.
  • TGFbeta exhibits a dual role, acting as a tumor suppressor in early stages and a promoter of invasion and metastasis in later stages.

Purpose of the Study:

  • To review the current understanding of TGFbeta signaling's role in skin carcinogenesis.
  • To elucidate the mechanisms behind TGFbeta's functional switch during cancer development.
  • To highlight the significance of TGFbeta signaling in epidermal homeostasis and skin tumor development.

Main Methods:

  • Review of existing literature on TGFbeta signaling in skin carcinogenesis.
  • Analysis of studies on chemical carcinogenesis in the epidermis.
  • Examination of findings related to mutations in TGFbeta receptors and Smad mediators.

Main Results:

  • TGFbeta signaling plays a complex role in skin carcinogenesis, inhibiting papilloma formation but promoting malignant conversion.
  • Deletion of the TGFbeta type II receptor accelerates skin carcinogenesis.
  • Mutations in TGFbeta receptors and Smads are linked to epithelial tumor development.

Conclusions:

  • TGFbeta signaling is a critical factor in skin carcinogenesis, with context-dependent effects.
  • Further research is needed to fully understand the mechanisms regulating TGFbeta's switch from tumor suppression to promotion.
  • Targeting TGFbeta signaling pathways may offer therapeutic strategies for skin cancer.

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...